Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

1.58
Delayed Data
As of Feb 21
 +0.03 / +1.94%
Today’s Change
1.47
Today|||52-Week Range
10.90
-9.20%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close1.55
Today’s open1.64
Day’s range1.56 - 1.64
Volume352,538
Average volume (3 months)518,199
Market cap$18.8M
Data as of 4:00pm ET, 02/21/2018

Growth & Valuation

Earnings growth (last year)+35.19%
Earnings growth (this year)+35.71%
Earnings growth (next 5 years)--
Revenue growth (last year)-56.64%
P/E ratioNM
Price/Sales21.49
Price/Book0.47

Competitors

 Today’s
change
Today’s
% change
APRIApricus Biosciences ...+0.01+0.88%
ACSTAcasti Pharma Inc-0.02-2.38%
HTBXHeat Biologics Inc-0.28-8.54%
KTOVKitov Pharma Ltd+0.04+1.55%
Data as of 4:00pm ET, 02/21/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$843.0K
Annual profit (last year)-$11.8M
Net profit margin-1,398.70%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts